● Recruiting

Phase IIa Trial in Participants With Asthma to Evaluate Impact of Intranasal ETH47 on Development of Asthma-related Symptoms Following Rhinovirus Challenge

Condition: Asthma (Diagnosis) · Sponsor: Ethris GmbH

PhasePhase 2

Planned participants50

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersNo

About this study

A Phase IIa trial in participants with asthma to evaluate the impact of intranasal ETH47 on the development of asthma-related symptoms following rhinovirus challenge

This description comes directly from the study's public registry record.

Talk to the study team

Dr. Philipp Schreppel · +4989244153042 · schreppel@ethris.com

Always discuss trial participation with your own doctor first.

Locations (2)

Imperial College Healthcare NHS Trust	London, United Kingdom	Recruiting
Medicines Evaluation Unit Limited	Manchester, United Kingdom	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07059767